CEO and Scientific Director
Giulio Superti-Furga, Ph.D., is Scientific Director and CEO of the Research Center of Molecular Medicine of the Austrian Academy of Sciences and a visiting professor at the Medical University of Vienna. He performed his undergraduate and graduate studies in molecular biology at the University of Zurich, Switzerland, at Genentech Inc., South San Francisco, USA, and at the Institute for Molecular Pathology in Vienna (I.M.P.), Austria. He was a post-doctoral fellow and Team Leader at the European Molecular Biology Laboratory (EMBL) until 2004. For several years he served as professor of Biotechnology at the University of Bologna. In 2000, he co-founded the biotech company Cellzome Inc., where he was Scientific Director and responsible for the Heidelberg research site. His most significant scientific contributions are the elucidation of basic regulatory mechanisms of tyrosine kinases in human cancers and the discovery of fundamental organization principles of the proteome of higher organisms. Giulio Superti-Furga is a member of the Austrian Academy of Sciences and of the German Academy of Sciences Leopoldina. An Italian national born 1962, Giulio Superti-Furga has an Austrian wife and two children.
Anita Ender was born in Schwaz, Tyrol in 1979. She attended a commercial school and is well grounded in human resources and administration management skills. She gained experience at the Institute for Biomedical Aging Research, a former research institute of the Austrian Academy of Sciences in Innsbruck, at the Institute for Pathophysiology at the Medical University Innsbruck, and worked for three years for the President of the Austrian Science Fund (FWF) before joining CeMM in 2005. She has played a major role in building up the institute taking care of human resources, being a highly considered dialogue partner for the Scientific Director and part of the management team. Since September 2013 Anita Ender has been the Administrative Director of CeMM responsible for all administrative and scientific support areas of the institute, and leading a team of 29 employees. Besides her duties at CeMM she is Chair of the Board of the newly founded Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases in Vienna, Member of the Intellectual Property Rights (IPR) Strategy Group at the Austrian Academy of Sciences, and work package leader of an EC-funded project called LIBRA “Leading Innovative measures to reach gender Balance in Research Activities“ coordinating recruitment guidelines for 10 top European research institutes in the life sciences.